Mission Statement
 AndroScience (ASC) focuses on innovating small molecules directed towards targets of high therapeutic and commercial value, including signaling and transcription factors, receptors, and intracellular signal cascades. Leveraging expertise in natural product chemistry, ASC’s robust in-house drug discovery and preclinical screening process advances novel drug candidates through early and mid-stage clinical testing in parallel across multiple clinical indications. Principle programs are based on treating diseases related to the Androgen Receptor (AR) and specific signal transducer and activation of transcription (STAT) activation pathways; with androgen dependent diseases in both topical and systemic treatment settings and novel cancer treatments constituting ASC’s major platform applications.
|